Targeting quinolone- and aminocoumarin-resistant bacteria with new gyramide analogs that inhibit DNA gyrase
Year: 2017
Type: article
Abstract: genes), overexpression of GyrA, GyrB, or GyrA and GyrB together does not suppress the inhibitory effect of the gyramides. These observations support the hypothesis that the gyramides inhibit DNA gyrase using a mechanism that is unique from other known inhibitors.
Source: MedChemComm
DOI: 10.1039/c7md00012j
Authors: Katherine A. Hurley, Thiago M. A. Santos, Molly R. Fensterwald, Madhusudan Rajendran, Jared T. Moore, Edward I. Balmond, Brice J. Blahnik, Katherine C. Faulkner, Marie H. Foss, Victoria A. Heinrich, Matthew G. Lammers, Lucas C. Moore, Gregory D. Reynolds, Galen P. Shearn-Nance, Brian A. Stearns, Zi W. Yao, Jared T. Shaw, Douglas B. Weibel
Language: English
Subfield: Molecular Medicine
Domain: Life Sciences
Open Access status: green
Funder: National Institutes of Health
OpenAlex ID: W2593539445
